Global Therapeutic Vaccines Market - Industry Analysis, Market Share, Size, Growth, Trends, And Forecast, 2012 - 2018

Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and development initiatives by pharmaceutical companies to develop novel vaccines for untapped disease segments.

Browse Report : http://www.transparencymarketresearch.com/therapeutic-vaccines-market.html

As a result of these initiatives, many more therapeutic vaccines are currently in the pipeline such as breast cancer vaccine, lung cancer vaccine; Alzheimer’s vaccine, malaria vaccine, and diabetes vaccine are expected to be introduced in the market during the period from 2012 to 2018. 

The market is currently facing growth hindrances as R&D approaches, and regulatory and reimbursement policies are inconspicuous owing to the nascent nature of the market. However, regulatory bodies are working enthusiastically to lay out policies and growth strategies, due to the fact that it holds the potential to solve or curb chronic diseases, with no currently available treatments, such as HIV AIDS.

our components hold imperative importance in designing a therapeutic vaccine:

Antigens: These are substances that evoke an immune response from the body and are responsible for the production of antibodies

Adjuvants: These are immunological agents that help in modifying the effects of a drug or vaccine. Companies are now engaged in designing new adjuvants that will help in enhancing the immunogenicity of an antigen

Cost effective production systems for vaccines

Designing innovative drug delivery devices to enhance vaccine efficacy

Browse Report : http://www.transparencymarketresearch.com/therapeutic-vaccines-market.html

The North American therapeutic vaccine market is expected to generate the maximum revenue in the global market during the forecasted period due to the presence of efficient R&D facilities and sophisticated medical infrastructures. The market is segmented into three major application segments namely oncology, infectious diseases and other chronic disorders.

The therapeutic vaccine market with oncology applications market held the majority of the market share in 2011, as most of the research and development exercises are expected to be directed towards this segment during 2012 to 2018.

Merck and GSK have strong therapeutic vaccine product pipelines and are expected to perform better during 2012 to 2018 than their competitors who have fewer products in the pipeline. Some of the other key players of the market include Sanofi-Pasteur, Cytos Biotechnology AG, and Intellect Neurosciences.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include :-

North America ,Asia Pacific ,Europe ,Rest of the World 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More

Global Multiple Sclerosis Drugs Market - Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018

Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing.

Browse Report : http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

There is no known cure for the disease currently and the only drugs available in the market are for delaying the progression of the disease. MS is estimated to affect 2.5 million people worldwide with around 5000 new cases developing each year. The National Multiple Sclerosis Society, Multiple Sclerosis Foundation, Multiple Sclerosis Association of America and several others are organizations which are determined to ensure improvement in the lives of affected people to make them more educated and spread awareness of this disease.

Until the last year, the MS drugs market was led primarily by injectables, yet this trend is changing very quickly to give way to oral MS drugs which is expected to grow strongly beginning from 2013. Gilenya and Aubagio are the top current oral drugs in this segment and Biogen’s oral BG-12 and Teva Laquinimod are two other drugs in the pipeline for approval with a significantly higher efficacy to be launched in the next five years. Although oral MS drugs seem to be growing quickly, it is not expected that they would unsettle injectables anytime soon. Several fatal side effects have been linked to use of Gilenya among those who have a heart disease and thus shows that there is still a long way to go for oral MS drugs.

Browse Report : http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

Top contenders in this segment till now are Copaxone, Avonex, Rebif, Betaseron, and Tysabri. Most of these drugs work actively to control MS relapses. Other treatments such as stem-cell transplantation are currently under investigation. The process includes the injection of stem cells which will replace the affected inflamed and diseased cells, greatly improving patient’s quality of life.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include : -

North America, Asia Pacific, Europe, Rest of the World 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More

MHealth Market - Global Mobile Health Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

According to a new market report published by Transparency Market Research "mHealth Market- Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global mHealth market is expected to reach USD 10.2 billion by 2018 from USD 1.3 billion in 2012 at a CAGR of 41.5% from 2012 to 2018. The monitoring services segment is in commanding position having contributed about 63% of the global mHealth market revenue in 2012.

Browse the full report at  http://www.transparencymarketresearch.com/mobile-health-market.html 

The global mHealth market is primarily driven by factors such as the increasing adoption of smartphones and rising incidences of chronic diseases. The development in smartphone applications has created new and interactive ways of communication between patients and healthcare providers. Use of smartphone applications is expected to revolutionize the mHealth market by improving healthcare delivery and dissemination of medical information.

The most impactful trend witnessed in the mHealth market is the growth in remote patient monitoring. Remote monitoring of patients can help reduce costs significantly by reducing the amount of time the patient spends in hospitals and also by lowering the frequency of follow-up visits to the physician. In addition, quick service and ease of use functionalities, and rising healthcare expenditure are supporting faster adoption of mHealth applications. Moreover, increasing demand for independent aging solutions and post-acute care services are also aiding the mHealth market growth.

The report analyzes the global mHealth market with cross sectional analysis of its various services and the players involved in the ecosystem. Based on the services, the market is segmented into - monitoring services, diagnostic services, healthcare system strengthening services and other services. The mHealth market ecosystem is analyzed in respect with major value system participants such as mobile operators, device vendors, content players and healthcare providers.

The monitoring services segment holds the largest share of about 63% of the global mHealth market followed by diagnostic services and healthcare systems strengthening. The monitoring services segment will also be the fastest growing during the forecast period, owing to their usability in acute conditions such as coronary artery disease, hypertension, and congestive heart failure. The contribution of monitoring services to the overall mHealth revenues will be greater in countries with higher income levels.

Within the mHealth participants' landscape, mobile operators hold majority of the market share of 50% followed by device vendors, content developers and healthcare providers. Mobile operators are gaining majority of the mHealth revenues from monitoring services, whereas diagnosis and treatment solutions will also be attractive opportunities for operators in the near future.

North America commands the largest share of mHealth market revenue followed by Europe and the Asia Pacific region. The current mHealth deployments in the Asia Pacific region are primarily focused on improving the efficiency of the healthcare workforce and systems. India is emerging as one of the mHealth hotspots in the region with a varied range of mHealth solution launches. Though the mHealth market has witnessed increasing influence of emerging economies, highest per capita expenditure on mHealth applications will continue to be from developed regions such as the U.S. and Canada, owing to an increasing percentage of chronic diseases and higher disposable income.

The mHealth market consists of a mix of players from different categories namely mobile operators, content developers, device vendors and healthcare providers. AT&T, AllScripts Healthcare Solutions, AirStrip Technologies, Qualcomm, Vodafone, Soft Serve, HealthSaaS and mQure are a few active key players across different categories mentioned above.

Browse the full report at  http://www.transparencymarketresearch.com/mobile-health-market.html 

Read More

Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research, the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.

The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.

The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are - molecular medicine, gene therapy, drug development and preventive medicine.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Read More

General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018

According to the latest market report published by Transparency Market Research "General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018", the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report at http://www.transparencymarketresearch.com/general-medicine-education-publishing.html 

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

General Medicine or internal medicine is a branch of medicine which deals with the prevention, diagnosis and subsequent treatment of adult diseases. The specialists who deal with this branch of medicine are called “internists” and ones who work with children are called pediatricians. General Medicine is further specialized depending on the organ or organ systems, such as cardiology, anesthesiology, endocrinology, nephrology etc. On an average 75,000 medical students choose internal medicine as a career option annually around the world. 

The global publishing market for general medicine education is highly dynamic in nature since there is a strong disparity in the availability and adoption of modern technology along with its cost. It is estimated that in the Asian and developing European regions along with RoW, more than half of the people do not have access to internet as a source of education in their homes. This severely undermines the quality of education. Printed books and literature are thus the major tools of spreading education here.

The report presents an excellent environmental analysis with emphasis on market drivers, restraints and future opportunities. It gives an impact of various factors on the market with a business perspective and highlights potential shortcomings, advantages for key players and new entrants as well. The global publishing market for general medicine education is highly dynamic in nature since there is a strong disparity in the availability and adoption of modern technology along with its cost. It is estimated that in the Asian and poorer European regions along with RoW, more than half of the people do not have access to internet as a source of education in their homes. This severely undermines the quality of education. Printed books and literature are thus the major tools of spreading education here.

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson's Principles and Practice of medicine.

A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:

Electronic & online publishing market for general medicine education

• Online Reference Tools
• Mobile Applications
• Electronic & Digital textbooks and reference books
• Multimedia Content
• Testing & Self-Assessmen
• Hospital Training
• Distance Learning

Print publishing market for general medicine education

• Custom content publishing
• Print textbooks and reference books
• Testing & Self-Assessment
• Hospital Training
• Distance Learning

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

North America

Europe

Asia

Rest of the World (RoW)

Browse the full report at http://www.transparencymarketresearch.com/general-medicine-education-publishing.html 

Read More

Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research , the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The “Bioinformatics Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 – 2018” report includes study of the global market for bioinformatics across different sub segments and geographies. The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are – molecular medicine, gene therapy, drug development and preventive medicine.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.

The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are - molecular medicine, gene therapy, drug development and preventive medicine.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

Read More

High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Growth, Share And Forecast, 2012 - 2018

In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments. Moreover, the report provides detailed and in-depth analysis of the HPAPI market, with their estimated figures and forecast from 2012 to 2018, along with compound annual growth rate from 2012 to 2018.

The global high-potency active pharmaceutical ingredients market has shown favorable growth trend in the last few years and is expected to grow rapidly in the forecasted period. The demand of oncology products is further expected to drive the growth of this market. The high level of competition in this market is due to new entrants fragmenting the market. HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018. The drivers, restraints and opportunities have also been covered broadly in this report along with their impact analysis. These market dynamics will be highly helpful in taking corporate decisions related to the HPAPI market.

High potency active pharmaceutical ingredients (HPAPIs) are growing rapidly as compared to other segments of the healthcare industry. HPAPI are the compounds helpful in the treatment of respiratory disorders, treatment of cancer and hormonal imbalances. Growing oncology therapeutics market worldwide is the key factor driving the growth of this market.

High Potency Active Pharmaceutical Ingredients Market is a growing concept and is considered to be a boost to the pharmaceutical industry. Patented high potency drug development majorly dominates the HPAPI market. The branded sector constitutes the major share of this market but the patents of this branded sector are expected to expire in the coming few years that will help HPAPI manufacturers to cater to multiple clients by producing the generic version of the ingredients in bulk.

Some of the factors driving this market at a rapid growth rate are majority of blockbuster drugs nearing patent expiry, US government promoting generic drugs to reduce its medical burden, insurance companies preferring generic drugs over patented drugs for cost effectiveness and India and China with maximum DMFs with the US FDA.

However, a large number of competitors are entering this market making it highly fragmented which may slow down the growth of this market. Moreover, reduced R&D investments leading to low demand of HPAPIs and shortage of US FDA approved manufacturing sites are also likely to be the major restraints for the growth of the high potency active pharmaceutical ingredients market.

However, North America has been the largest market for high potency pharmaceutical ingredients as the country spends highly on the development of healthcare systems, whereas the European market has experienced several fluctuations in the past few years but is expected to grow rapidly in the near future due to rise in the demand of oncology drugs in this region.

Browse Report : http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

Read More